NASDAQ: NEOG
Neogen Corp Stock

$11.47-0.27 (-2.3%)
Updated Jan 24, 2025
NEOG Price
$11.47
Fair Value Price
$5.26
Market Cap
$2.49B
52 Week Low
$10.72
52 Week High
$18.58
P/E
-5.24x
P/B
0.93x
P/S
3.36x
PEG
N/A
Dividend Yield
N/A
Revenue
$913.83M
Earnings
-$476.33M
Gross Margin
49.1%
Operating Margin
-47.14%
Profit Margin
-52.1%
Debt to Equity
0.52
Operating Cash Flow
$19M
Beta
1
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NEOG Overview

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine NEOG's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Value
C
Growth
D
Momentum
F
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Diagnostic & Research

Industry Rating
C
NEOG
Ranked
#48 of 55

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$136.22A
$45.63A
$167.61B
View Top Diagnostic & Research Stocks

Be the first to know about important NEOG news, forecast changes, insider trades & much more!

NEOG News

Overview

Due Diligence Score

Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NEOG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NEOG ($11.47) is overvalued by 117.96% relative to our estimate of its Fair Value price of $5.26 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
NEOG ($11.47) is not significantly undervalued (117.96%) relative to our estimate of its Fair Value price of $5.26 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
NEOG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NEOG due diligence checks available for Premium users.

Valuation

NEOG fair value

Fair Value of NEOG stock based on Discounted Cash Flow (DCF)

Price
$11.47
Fair Value
$5.26
Overvalued by
117.96%
NEOG ($11.47) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NEOG ($11.47) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NEOG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NEOG price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-5.24x
Industry
25.67x
Market
30.33x

NEOG price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.93x
Industry
4.23x
NEOG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NEOG's financial health

Profit margin

Revenue
$231.3M
Net Income
-$456.3M
Profit Margin
-197.3%
NEOG's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NEOG's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$4.1B
Liabilities
$1.4B
Debt to equity
0.52
NEOG's short-term assets ($570.45M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NEOG's long-term liabilities ($1.23B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NEOG's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NEOG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$40.3M
Investing
-$17.2M
Financing
-$1.4M
NEOG's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NEOG vs Diagnostic & Research Stocks

TickerZen RatingMarket Cap1d %P/EP/B
NEOGC$2.49B-2.30%-5.24x0.93x
NEOC$1.91B+1.36%-24.36x2.10x
TWSTC$3.21B+1.44%-15.02x6.79x
CDNAB$1.20B-4.65%-8.30x4.38x
MYGNB$1.17B+0.47%-10.02x1.60x

Neogen Stock FAQ

What is Neogen's quote symbol?

(NASDAQ: NEOG) Neogen trades on the NASDAQ under the ticker symbol NEOG. Neogen stock quotes can also be displayed as NASDAQ: NEOG.

If you're new to stock investing, here's how to buy Neogen stock.

What is the 52 week high and low for Neogen (NASDAQ: NEOG)?

(NASDAQ: NEOG) Neogen's 52-week high was $18.58, and its 52-week low was $10.72. It is currently -38.27% from its 52-week high and 7% from its 52-week low.

How much is Neogen stock worth today?

(NASDAQ: NEOG) Neogen currently has 216,944,017 outstanding shares. With Neogen stock trading at $11.47 per share, the total value of Neogen stock (market capitalization) is $2.49B.

Neogen stock was originally listed at a price of $1.01 in Dec 31, 1997. If you had invested in Neogen stock at $1.01, your return over the last 27 years would have been 1,033.4%, for an annualized return of 9.41% (not including any dividends or dividend reinvestments).

How much is Neogen's stock price per share?

(NASDAQ: NEOG) Neogen stock price per share is $11.47 today (as of Jan 24, 2025).

What is Neogen's Market Cap?

(NASDAQ: NEOG) Neogen's market cap is $2.49B, as of Jan 26, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Neogen's market cap is calculated by multiplying NEOG's current stock price of $11.47 by NEOG's total outstanding shares of 216,944,017.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.